| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $908,687 ) |
| | 2025 | 2025 | CELLDOM INC | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R44CA281575 | High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures | 000 | 2 | NIH | 4/7/2025 | $908,687 |
|
| Issue Date FY: 2024 ( Subtotal = $938,647 ) |
| | 2024 | 2024 | CELLDOM INC | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R44CA281575 | High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures | 000 | 1 | NIH | 4/19/2024 | $938,647 |
| | 2024 | 2022 | CELLDOM INC | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R44GM128472 | Platform for genotyping and phenotyping each cell in a high throughput assay | 000 | 3 | NIH | 5/10/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $831,964 ) |
| | 2022 | 2022 | CELLDOM, INC. | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R44GM128472 | Platform for genotyping and phenotyping each cell in a high throughput assay | 000 | 3 | NIH | 8/25/2022 | $831,964 |
|
| Issue Date FY: 2021 ( Subtotal = $831,964 ) |
| | 2021 | 2021 | CELLDOM, INC. | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R44GM128472 | Platform for genotyping and phenotyping each cell in a high throughput assay | 000 | 2 | NIH | 9/21/2021 | $831,964 |
| | 2021 | 2019 | CELLDOM, INC. | 733 INDUSTRIAL RD | SAN CARLOS | CA | 94070-3310 | SAN MATEO | USA | R44GM122149 | High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity | 000 | 3 | NIH | 2/6/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | CELLDOM, INC. | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R43GM128472 | Platform for genotyping and phenotyping each cell in a high throughput assay | 000 | 1 | NIH | 5/8/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,027,037 ) |
| | 2019 | 2019 | CELLDOM, INC. | 701 W MAIN ST STE 200 | DURHAM | NC | 27701-5012 | DURHAM | USA | R44GM122149 | High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity | 000 | 3 | NIH | 8/23/2019 | $728,478 |
| | 2019 | 2019 | CELLDOM, INC. | 1 STONEHOUSE CT | DURHAM | NC | 27713-6107 | DURHAM | USA | R43GM128472 | Platform for genotyping and phenotyping each cell in a high throughput assay | 000 | 1 | NIH | 12/19/2018 | $298,559 |
|
| Issue Date FY: 2018 ( Subtotal = $751,561 ) |
| | 2018 | 2018 | CELLDOM, INC. | 1 STONEHOUSE CT | DURHAM | NC | 27713-6107 | DURHAM | USA | R44GM122149 | High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity | 000 | 2 | NIH | 8/21/2018 | $751,561 |
| | 2018 | 2017 | CELLDOM, INC. | 1 STONEHOUSE CT | DURHAM | NC | 27713-6107 | DURHAM | USA | R43GM122149 | High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity | 000 | 1 | NIH | 1/19/2018 | $0 |
| | 2018 | 2017 | CELLDOM, INC. | 1 STONEHOUSE CT | DURHAM | NC | 27713-6107 | DURHAM | USA | R43GM122149 | High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity | 001 | 1 | NIH | 5/10/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $224,907 ) |
| | 2017 | 2017 | CELLDOM, INC. | 1 STONEHOUSE CT | DURHAM | NC | 27713-6107 | DURHAM | USA | R43GM122149 | High-throughput screening of arrayed single cells for automated analysis of phenotypic heterogeneity | 000 | 1 | NIH | 1/5/2017 | $224,907 |
|
|
